- Home
- AVTX vs TMQ Comparison
AVTX vs TMQ Comparison
Compare AVTX & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- TMQ
- Stock Information
- Founded
- AVTX 2011
- TMQ 2004
- Country
- AVTX United States
- TMQ Canada
- Employees
- AVTX N/A
- TMQ N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- TMQ Precious Metals
- Sector
- AVTX Health Care
- TMQ Basic Materials
- Exchange
- AVTX Nasdaq
- TMQ Nasdaq
- Market Cap
- AVTX 248.3M
- TMQ 249.6M
- IPO Year
- AVTX 2015
- TMQ N/A
- Fundamental
- Price
- AVTX $14.00
- TMQ $7.08
- Analyst Decision
- AVTX Strong Buy
- TMQ
- Analyst Count
- AVTX 9
- TMQ 0
- Target Price
- AVTX $30.14
- TMQ N/A
- AVG Volume (30 Days)
- AVTX 445.0K
- TMQ 30.8M
- Earning Date
- AVTX 11-06-2025
- TMQ 09-30-2025
- Dividend Yield
- AVTX N/A
- TMQ N/A
- EPS Growth
- AVTX N/A
- TMQ N/A
- EPS
- AVTX N/A
- TMQ N/A
- Revenue
- AVTX $441,000.00
- TMQ N/A
- Revenue This Year
- AVTX N/A
- TMQ N/A
- Revenue Next Year
- AVTX N/A
- TMQ N/A
- P/E Ratio
- AVTX N/A
- TMQ N/A
- Revenue Growth
- AVTX N/A
- TMQ N/A
- 52 Week Low
- AVTX $3.39
- TMQ $0.52
- 52 Week High
- AVTX $16.00
- TMQ $11.29
- Technical
- Relative Strength Index (RSI)
- AVTX 61.63
- TMQ 62.16
- Support Level
- AVTX $13.21
- TMQ $6.00
- Resistance Level
- AVTX $15.99
- TMQ $11.29
- Average True Range (ATR)
- AVTX 1.19
- TMQ 1.08
- MACD
- AVTX -0.04
- TMQ 0.50
- Stochastic Oscillator
- AVTX 44.43
- TMQ 54.63
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.